Trial intelligence / Profile preview

N-Acetylcysteine in Stage 3 Chronic Kidney Disease

NCT00506506Phase 3Completed

Start
Oct 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in chronic kidney disease (CKD). Started Oct 2007; status: completed.

02

Drugs

acetylcysteine
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT00506506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00506506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call